483
Alembic Pharmaceuticals LimitedAlembic Pharmaceuticals Limited – FDA 483, Mar 24, 2023
Record Details
Alembic Pharmaceuticals Limited, a sterile drug manufacturer, received a Form FDA 483 citing significant quality control deficiencies. Observations included the failure of the quality control unit to adequately review and approve drug product production records for contract manufactured batches prior to release. Additionally, the quality control unit lacked proper oversight, and internal audit procedures were found to be inadequate, with issues related to auditor training and audit scope.
View Company Profile
ID · 7a4acca6-9c41-40e2-a37e-a19fe33c8bd5
Other documents for Alembic Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.